TabletsTablets
Schedule H1 (Prescription Required - Habit Forming Warning)Anxiolytics & SedativesCode: 2549

Etizolam 0.5mg + Escitalopram Oxalate 10mg Tablets

Generic Formulation:Etizolam 0.5mg and Escitalopram Oxalate 10mg Tablets
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹18.75
Brand Estimate*
₹38.7
Estimated Savings:₹19.95 (52% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Etizolam and Escitalopram combines a fast-acting thienodiazepine with a selective serotonin reuptake inhibitor. Etizolam acts rapidly within 30-60 minutes to suppress acute anxiety, muscle tension, and insomnia, while escitalopram normalizes central serotonergic tone to treat chronic depression and anxiety. Indicated for comorbid depression and anxiety, panic disorder, and acute stress disorders.

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2549.Report inaccuracy

Usage Guidelines

Take orally once daily, preferably in the evening with water, with or without food. Do not stop abruptly. Complete the prescribed tapering schedule.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Somnolence, dry mouth, nausea, dizziness, fatigue, headache, decreased libido. Rare/Severe: Serotonin syndrome, suicidal ideation, dependence liability, and severe withdrawal symptoms.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Boxed warning for suicidality in young patients and dependence on sedative-hypnotics. Contraindicated with MAOIs. Avoid alcohol.

Schedule H1 (Prescription Required - Habit Forming Warning)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.